期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 10, 期 10, 页码 549-550出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2013.152
关键词
-
类别
Two phase III trials have shown that prolonging chemotherapy duration improves outcome in patients with nonsquamous non-small-cell lung cancer. Pemetrexed versus placebo, and pemetrexed-bevacizumab versus bevacizumab was tested in patients without disease progression after pemetrexed-cisplatin treatment. Biomarker-directed chemotherapy and/or targeted therapy could further improve treatment outcomes for patients with lung cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据